SI-BONE, Inc. (SIBN)
Stock Price:
$16.11 USD
-0.15 (-0.92%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
457.96M |
| Revenue (ttm) |
69.13M |
| Net Income (ttm) |
-41.83M |
| Shares Out |
28.43M |
| EPS (ttm) |
-1.65 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$16.11 |
| Previous Close |
$16.26 |
| Change ($) |
-0.15 |
| Change (%) |
-0.92% |
| Day's Open |
16.28 |
| Day's Range |
15.95 - 16.52 |
| Day's Volume |
173,837 |
| 52-Week Range |
7.20 - 23.10 |
More Stats
| Market Cap |
457.96M |
| Enterprise Value |
352.31M |
| Earnings Date (est) |
Aug 11, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
28.43M |
| Float |
22.68M |
| EPS (basic) |
-1.64 |
| EPS (diluted) |
-1.65 |
| FCF / Share |
-1.35 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
350,796 |
| Short Ratio |
2.34 |
| Short % of Float |
1.40% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
6.62 |
| PB Ratio |
3.82 |
| Revenue |
69.13M |
| Operating Income |
-39.09M |
| Net Income |
-41.83M |
| Free Cash Flow |
-36.82M |
| Net Cash |
105.65M |
| Net Cash / Share |
3.72 |
| Gross Margin |
87.53% |
| Operating Margin |
-56.54% |
| Profit Margin |
-60.50% |
| FCF Margin |
-53.26% |
| ROA |
-14.96% |
| ROE |
-42.04% |
| ROIC |
-28.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (7)
| Buy |
7 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$23.86*
(48.11% upside)
Low
20.0
Current: 16.11
High
28.0
Target: 23.86
*Average 12-month price target from 7 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 67.30 | 55.38 | 47.98 | 42.10 |
| Revenue Growth | 21.53% | 15.42% | 13.97% | - |
| Gross Profit | 60.51 | 50.55 | 42.87 | 36.94 |
| Operating Income | -36.00 | -11.97 | -17.35 | -17.57 |
| Net Income | -38.40 | -17.45 | -23.04 | -20.59 |
| Shares Outstanding | 24.71 | 7.95 | 3.47 | 3.31 |
| Earnings Per Share | -1.55 | -2.20 | -6.65 | -6.21 |
| Operating Cash Flow | -31.63 | -14.52 | -17.53 | -16.75 |
| Capital Expenditures | -2.45 | -0.94 | -0.48 | -0.44 |
| Free Cash Flow | -34.07 | -15.46 | -18.01 | -17.19 |
| Cash & Equivalents | 91.78 | 122 | 22.41 | 27.90 |
| Total Debt | 39.22 | 38.96 | 38.70 | 29.31 |
| Net Cash / Debt | 52.56 | 83.26 | -16.30 | -1.41 |
| Assets | 117 | 139 | 35.83 | 39.44 |
| Liabilities | 54.00 | 48.33 | 46.66 | 35.05 |
| Book Value | 63.01 | 90.19 | -129 | -109 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
SI-BONE, Inc. |
| Country |
United States |
| Employees |
262 |
| CEO |
Jeffrey W. Dunn |
Stock Information
| Ticker Symbol |
SIBN |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: SIBN |
| IPO Date |
October 17, 2018 |
Description
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was founded in 2008 and is headquartered in Santa Clara, California.